MLYS logo

Mineralys Therapeutics (MLYS) Free cash flow

annual FCF:

-$166.41M-$85.24M(-105.01%)
December 31, 2024

Summary

  • As of today (June 17, 2025), MLYS annual free cash flow is -$166.41 million, with the most recent change of -$85.24 million (-105.01%) on December 31, 2024.
  • During the last 3 years, MLYS annual FCF has fallen by -$151.85 million (-1043.00%).
  • MLYS annual FCF is now -6656.39% below its all-time high of -$2.46 million, reached on December 1, 2020.

Performance

MLYS Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

quarterly FCF:

-$45.49M+$21.36M(+31.95%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS quarterly free cash flow is -$45.49 million, with the most recent change of +$21.36 million (+31.95%) on March 31, 2025.
  • Over the past year, MLYS quarterly FCF has dropped by -$26.29 million (-136.94%).
  • MLYS quarterly FCF is now -731.72% below its all-time high of -$5.47 million, reached on June 1, 2022.

Performance

MLYS quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

TTM FCF:

-$192.70M-$26.29M(-15.80%)
March 31, 2025

Summary

  • As of today (June 17, 2025), MLYS TTM free cash flow is -$192.70 million, with the most recent change of -$26.29 million (-15.80%) on March 31, 2025.
  • Over the past year, MLYS TTM FCF has dropped by -$105.10 million (-119.99%).
  • MLYS TTM FCF is now -2829.45% below its all-time high of -$6.58 million, reached on March 1, 2022.

Performance

MLYS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMLYScash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

MLYS Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-105.0%-136.9%-120.0%
3 y3 years-1043.0%-591.5%-2829.4%
5 y5 years-6656.4%--

MLYS Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1043.0%at low-731.7%+31.9%-1499.6%at low
5 y5-year-6656.4%at low-731.7%+31.9%-2829.4%at low
alltimeall time-6656.4%at low-731.7%+31.9%-2829.4%at low

MLYS Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
-$45.49M(-31.9%)
-$192.70M(+15.8%)
Dec 2024
-$166.41M(+105.0%)
-$66.84M(+33.1%)
-$166.41M(+29.5%)
Sep 2024
-
-$50.22M(+66.6%)
-$128.55M(+32.0%)
Jun 2024
-
-$30.15M(+57.0%)
-$97.36M(+11.1%)
Mar 2024
-
-$19.20M(-33.8%)
-$87.60M(+7.9%)
Dec 2023
-$81.17M
-$28.98M(+52.3%)
-$81.17M(+30.1%)
Sep 2023
-
-$19.03M(-6.6%)
-$62.38M(+23.9%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$20.39M(+59.6%)
-$50.34M(+42.1%)
Mar 2023
-
-$12.78M(+25.4%)
-$35.42M(+21.2%)
Dec 2022
-$29.22M(+100.7%)
-$10.19M(+45.8%)
-$29.22M(+53.5%)
Sep 2022
-
-$6.99M(+27.8%)
-$19.04M(+58.0%)
Jun 2022
-
-$5.47M(-16.9%)
-$12.05M(+83.1%)
Mar 2022
-
-$6.58M
-$6.58M
Dec 2021
-$14.56M(+491.1%)
-
-
Dec 2020
-$2.46M
-
-

FAQ

  • What is Mineralys Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual FCF year-on-year change?
  • What is Mineralys Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly FCF year-on-year change?
  • What is Mineralys Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics TTM FCF year-on-year change?

What is Mineralys Therapeutics annual free cash flow?

The current annual FCF of MLYS is -$166.41M

What is the all time high annual FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual free cash flow is -$2.46M

What is Mineralys Therapeutics annual FCF year-on-year change?

Over the past year, MLYS annual free cash flow has changed by -$85.24M (-105.01%)

What is Mineralys Therapeutics quarterly free cash flow?

The current quarterly FCF of MLYS is -$45.49M

What is the all time high quarterly FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly free cash flow is -$5.47M

What is Mineralys Therapeutics quarterly FCF year-on-year change?

Over the past year, MLYS quarterly free cash flow has changed by -$26.29M (-136.94%)

What is Mineralys Therapeutics TTM free cash flow?

The current TTM FCF of MLYS is -$192.70M

What is the all time high TTM FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high TTM free cash flow is -$6.58M

What is Mineralys Therapeutics TTM FCF year-on-year change?

Over the past year, MLYS TTM free cash flow has changed by -$105.10M (-119.99%)
On this page